ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AKR Akers Bio

57.50
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Akers Bio LSE:AKR London Ordinary Share COM SHS NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 57.50 50.00 65.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Akers Biosciences Share Discussion Threads

Showing 3876 to 3898 of 3900 messages
Chat Pages: 156  155  154  153  152  151  150  149  148  147  146  145  Older
DateSubjectAuthorDiscuss
25/12/2018
12:31
Merry Xmas to any other poor soul(s) still left here.
algernon2
19/12/2018
10:19
literally. Yes indeed. here's hoping for a share price "high" then.
algernon2
18/12/2018
20:28
Looks like AKR are going to pot
buywell3
18/12/2018
17:50
"Bah Humbug" to Akers Biosciences and Raymond Akers. But a Very Merry Xmas to everyone here past present and future.
algernon2
20/11/2018
12:43
MCDid they consolidate 1 for 10?I think they must be confident of a lump out of Aker to hang in there on meagerHeparin
sambocoole
21/10/2018
21:33
" Outlining the Class Action Lawsuit Against Akers Biosciences, Inc. Securities "
algernon2
26/9/2018
18:43
Ho Hum! the sound of Tumbleweed blowing through the AKR BB.Not heard anything about the impending lawsuits. Any one any news or thoughts or ideas to add to the mix?
algernon2
11/8/2018
22:46
A bounce from 21 to 28 cents on the nasdaq , may hold a different story .
I am a holder for the forseable .

Best of All

bbr391
11/8/2018
14:35
Friday , at around 20p a share = £2,600 worth traded = 43.33% rise

21.50
TODAY'S CHANGE
6.50 / 43.33%
SHARES TRADED
12.89k

buywell3
10/8/2018
21:59
Highly suspicious past Indeed .
The future holds several surprises here .
That Is why I am now a long term holder , through these shenanigans .

Best of All

bbr391
28/7/2018
13:42
Thanks Buywell,sent them an email yesterday but not holding my breath as they have not replied before when asked on other matters.
I did get one reply once a long while ago when I enquired about visiting.

algernon2
28/7/2018
11:01
Good luck with that one
buywell3
27/7/2018
10:49
Yes this class action ongoing re investors who bought shares between certain dates should also include those who owned and held shares during those dates; as we held those shares rather than selling them , based on the same information or disinformation that the buyers may be suing Akers over.
Discuss.
I would (might have) have sold rather than held if I had access to accurate information and figures earlier; so I have sustained a loss here.
Maybe the law firms looking at the issue could cast their nets a bit wider if they believe or can prove "evil" or "skullduggery" or "stupidity and laxness" has been at work.
I shall send Akers the suggestion they respond via ADVFN BB to the comments if they have anything to say.

algernon2
27/7/2018
10:40
Today


PRICE (GBX)
19.00

TODAY'S CHANGE
1.50 / 8.57%

SHARES TRADED
18.58k


What a larf

buywell3
26/7/2018
12:19
Akers Biosciences (AKR) News Out Just Now
danieldanj
18/7/2018
14:37
Akers Biosciences (AKR) News Out Just Now
danieldanj
18/7/2018
11:55
As feared, Gormally seems to have as much of a clue re PIFA Heparin / it's efficacy / selling it / etc as Walt; this is the fella who, following GNYHA having informally given the go ahead for the device to be sold in Puerto Rico, said "release the hounds". A very unusual thing for a grown man - nevermind a CEO - to say in my opinion. This is about the 15th new strategy to try to sell their 'flagship' device....

"....The Company is taking steps to improve its market presence for PIFA Heparin PF/4 Rapid Assay products including through the use of specialized Independent Sales Representatives (ISRs) and through a program to educate the marketplace through the preparation and publication of additional clinical studies"

mcmather
14/7/2018
09:55
Akers Biosciences (AKR) Earnings-Reaction to Keep an Eye
danieldanj
13/7/2018
23:36
Akers Biosciences (AKR) News Out Just Now
danieldanj
30/6/2018
18:20
Still time to look at Akers Biosciences (AKR) - Upcoming Key Date
danieldanj
29/6/2018
15:02
All you guys that ramped this POS

Should say you are sorry

buywell3
20/6/2018
13:00
Is Walt getting ready for a knock at the door?

"The Company is currently unable to quantify the level of recognisable revenues for the periods covered in these Reports, however it is expected that revenues will be lower than previously reported and losses for these periods will be greater".

mcmather
17/6/2018
18:20
How come there is a rns (see below) on Nasdaq but not yet on here?
----------
"...The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. On May 21, 2018, Akers announced that it was unable to file its Form 10-Q quarterly report with the SEC for the period ending March 31, 2018. The Company added that its internal review has expanded to include the “characterization of certain revenue recognition items . . . now includes certain transactions in previous quarters.” On May 22, 2018, shares of Akers fell more than 8% based on this news. On May 29, 2018, Akers announced that “Raymond F. Akers Jr., Ph.D. has resigned as a director of the Company with immediate effect.” Akers shares fell 33% the same day based on this announcement. On June 1, the Company released a letter to the SEC from Dr. Raymond Akers stating that he “resigned from the Board of Directors due to significant differences regarding the policies and practices of the Board of Directors, accounting and business practices of Management, and new Counsel.”

If you are a shareholder who suffered a loss, click here to participate....."

algernon2
Chat Pages: 156  155  154  153  152  151  150  149  148  147  146  145  Older

Your Recent History

Delayed Upgrade Clock